检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A biomarker study of atezolizumab (atezo) plus bevacizumab (bev) plus carboplatin (carbo) plus paclitaxel (pac) (ABCP) for patients with NSCLC harboring EGFR mutations (EGFRm) after failure of TKI therapy: NEJ043

Satoshi Watanabe,Naoki Furuya,Atsushi Nakamura,Jun Shiihara, Ichiro Nakachi,Hisashi Tanaka,Mika Nakao,Koichi Minato,Masahiro Seike,Shinichi Sasaki, Akira Kisohara,Susumu Takeuchi,Ryoichi Honda,Kei Takamura,Yiwei Ling,Shujiro Okuda,Hiroshi Kagamu,Kenichi Yoshimura,Toshiaki Kikuchi,Kunihiko Kobayashi

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要